# Expanded Access Program for Avapritinib

> **NCT04714086** · — · NO_LONGER_AVAILABLE · sponsor: **Blueprint Medicines Corporation**

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Avapritinib

## Key facts

- **NCT ID:** NCT04714086
- **Lead sponsor:** Blueprint Medicines Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714086, "Expanded Access Program for Avapritinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04714086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*